Evidence map›Paper›PMID 40872288›Full record

ArticlePathogens (Basel, Switzerland)2025

Nylon Affinity Networks Capture and Sequester Two Model Bacteria Spiked in Human Plasma.

Fatema Hashemi, Silvia Cachaco, Rocio Prisby, Weidong Zhou, Gregory Petruncio, Elsa Ronzier, Remi Veneziano, Barbara Birkaya, Alessandra Luchini, Luisa Gregori

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fatema HashemiDivision of Emerging Transfusion-Transmitted Diseases, Office of Blood Research and Review, Food and Drug Administration, Silver Spring, MD 20993, USA.
Silvia CachacoDivision of Emerging Transfusion-Transmitted Diseases, Office of Blood Research and Review, Food and Drug Administration, Silver Spring, MD 20993, USA.
Rocio PrisbyCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Weidong ZhouCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Gregory PetruncioCenter for Molecular Engineering, Department of Chemistry & Biochemistry, George Mason University, Manassas, VA 20110, USA.
Elsa RonzierBiomedical Research Laboratory, Institute for Biohealth Innovation, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0003-1008-4271
Remi VenezianoDepartment of Bioengineering, College of Engineering and Computing, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0002-2726-3770
Barbara BirkayaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Alessandra LuchiniCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0003-1599-0214
Luisa GregoriDivision of Emerging Transfusion-Transmitted Diseases, Office of Blood Research and Review, Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0001-5093-3472

Funding

FDA HHS To be provided
6 · The paper itself

Abstract

Ensuring bacterial safety of blood transfusions remains a critical focus in medicine. We investigated a novel pathogen reduction technology utilizing nylon functionalized with synthetic dyes (nylon affinity networks) to capture and remove bacteria from plasma. In the initial screening process, we spiked phosphate buffer solution (PBS) and human plasma (1 mL each) with 10 or 100 colony forming units (cfu) of either

Indexed as

Blood SafetyEscherichia coliNylonsPlasmaStaphylococcus epidermidisColoring AgentsHumansColoring AgentsNylonsAlcian Bluebacterial capturenylon affinity networkspathogen reduction technologysynthetic dyestransfusion safety

Identifiers

PMID40872288
PMCPMC12389278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.